• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微剂量阴道内左炔诺孕酮避孕:一项多中心临床试验。III. 妊娠率与体重之间的关系。世界卫生组织。长效全身生育调节制剂特别工作组

Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. III. The relationship between pregnancy rate and body weight. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation.

作者信息

Koetsawang S, Ji G, Krishna U, Cuadros A, Dhall G I, Wyss R, Rodriquez la Puenta J, Andrade A T, Khan T, Kononova E S

机构信息

Department of Obstetrics and Gynaecology, Siriraj Hospital, Bangkok, Thailand.

出版信息

Contraception. 1990 Feb;41(2):143-50. doi: 10.1016/0010-7824(90)90143-j.

DOI:10.1016/0010-7824(90)90143-j
PMID:2107056
Abstract

This paper investigates the relationship between pregnancy rates and body weight of 1005 women using a vaginal ring releasing 20 micrograms levonorgestrel per 24 hours. While the overall pregnancy rate at one year was 3.7%, it was found that women have an increasing risk of pregnancy with increasing body weight. For example, a woman of 40 kg has an estimated pregnancy rate of 1.7% in contrast to 9.8% for a woman of 80 kg weight.

摘要

本文研究了1005名使用每24小时释放20微克左炔诺孕酮阴道环的女性的妊娠率与体重之间的关系。虽然一年的总体妊娠率为3.7%,但发现女性体重增加时妊娠风险也会增加。例如,一名40公斤的女性估计妊娠率为1.7%,而一名80公斤的女性为9.8%。

相似文献

1
Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. III. The relationship between pregnancy rate and body weight. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation.微剂量阴道内左炔诺孕酮避孕:一项多中心临床试验。III. 妊娠率与体重之间的关系。世界卫生组织。长效全身生育调节制剂特别工作组
Contraception. 1990 Feb;41(2):143-50. doi: 10.1016/0010-7824(90)90143-j.
2
Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. I. Contraceptive efficacy and side effects. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation.微剂量阴道内左炔诺孕酮避孕:一项多中心临床试验。I. 避孕效果和副作用。世界卫生组织。生育调节长效全身用药特别工作组。
Contraception. 1990 Feb;41(2):105-24. doi: 10.1016/0010-7824(90)90141-h.
3
Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. II. Expulsions and removals. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation.
Contraception. 1990 Feb;41(2):125-41. doi: 10.1016/0010-7824(90)90142-i.
4
Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. IV. Bleeding patterns. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation.微剂量阴道内左炔诺孕酮避孕:一项多中心临床试验。IV. 出血模式。世界卫生组织。生育调节长效全身用药特别工作组。
Contraception. 1990 Feb;41(2):151-67. doi: 10.1016/0010-7824(90)90144-k.
5
Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.两种经阴道给药避孕药的疗效和可接受性比较研究:一项国际多中心临床试验。
Clin Pharmacol Ther. 1993 Jan;53(1):65-75. doi: 10.1038/clpt.1993.10.
6
Microdose intrauterine levonorgestrel for contraception. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction: Task Force on Intrauterine Devices for Fertility Regulation.微量宫内左炔诺孕酮避孕。世界卫生组织人类生殖研究、发展与研究培训特别规划:生育调节宫内节育器特别工作组。
Contraception. 1987 Apr;35(4):363-79.
7
The efficacy and acceptability of a low-dose levonorgestrel intravaginal ring for contraception in a UK cohort.低剂量左炔诺孕酮阴道环在英国某队列中用于避孕的有效性和可接受性。
Contraception. 1991 Feb;43(2):129-37. doi: 10.1016/0010-7824(91)90040-m.
8
Clinical performance of a levonorgestrel-releasing intracervical contraceptive device during the first year of use.左炔诺孕酮宫内节育器使用第一年的临床性能
Contraception. 1987 Dec;36(6):659-66. doi: 10.1016/0010-7824(87)90039-4.
9
Menstrual blood loss with use of a vaginal ring releasing 20 micrograms levonorgestrel per day. World Health Organization. Task force on long-acting systemic agents for fertility regulation.
Contraception. 1993 May;47(5):455-68.
10
Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study.左炔诺孕酮20微克/天(LNG 20)和铜T 380Ag宫内节育器的长期避孕效果:一项为期五年的随机研究。
Contraception. 1990 Oct;42(4):361-78. doi: 10.1016/0010-7824(90)90046-x.

引用本文的文献

1
Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women.随机、安慰剂对照的 I 期临床试验,评估了替诺福韦和替诺福韦加左炔诺孕酮阴道环在女性中的安全性、药代动力学、药效学和可接受性。
PLoS One. 2018 Jun 28;13(6):e0199778. doi: 10.1371/journal.pone.0199778. eCollection 2018.
2
Hormonal contraceptives for contraception in overweight or obese women.超重或肥胖女性避孕用激素避孕药
Cochrane Database Syst Rev. 2016 Aug 18;2016(8):CD008452. doi: 10.1002/14651858.CD008452.pub4.
3
Pipeline for contraceptive development.
避孕药具研发流程。
Fertil Steril. 2016 Nov;106(6):1295-1302. doi: 10.1016/j.fertnstert.2016.07.1115. Epub 2016 Aug 11.